Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749786 · ClinicalTrials.gov registry record · NA
Genetic Basis of Rosacea Study (Control)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02749786: Completed NA study, sponsored by Stanford University.
NCT02749786 is a NA study that has completed, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02749786, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.
Interventions
- OTHER Skin Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-01-21 |
| Est. Completion | 2016-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02749786
The ClinicalTrials.gov registry entry for NCT02749786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Skin Biopsy is the first listed.
NCT02749786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02749786 about?
NCT02749786 is a clinical study titled "Genetic Basis of Rosacea Study (Control)". Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinoph...
What is the current status of trial NCT02749786?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-01-21. Estimated completion is 2016-08-01.
What interventions are being tested in trial NCT02749786?
The interventions under investigation include: Skin Biopsy (OTHER).
Who is sponsoring clinical trial NCT02749786?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.